A novel role for mitochondria in regulating epigenetic modifications in the nucleus

Epigenetic modification in the nuclear genome plays a key role in human tumorigenesis. In this paper, we investigated whether changes in the mtDNA copy number frequently reported to vary in a number of human tumors induce methylation changes in the nucleus. We utilized the Restriction Landmark Genomic Scanning (RLGS) to identify genes that undergo changes in their methylation status in response to the depletion and repletion of mtDNA. Our study demonstrates that depletion of mtDNA results in significant changes in methylation pattern of a number of genes. Furthermore, our study suggests that methylation changes are reversed by the restoration of mtDNA in cells otherwise lacking the entire mitochondrial genome. These studies provide the first direct evidence that mitochondria regulate epigenetic modification in the nucleus that may contribute to tumorigenesis.

[1]  Y. Hayashizaki,et al.  A genomic scanning method for higher organisms using restriction sites as landmarks. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[3]  Y. Hayashizaki,et al.  New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. , 1992, Cancer research.

[4]  Sushant Kachhap,et al.  Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells , 2002, Molecular Cancer.

[5]  J. T. Wachsman,et al.  Mitochondrial DNA in human malignancy. , 2001, Mutation research.

[6]  L. Rasmussen,et al.  Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. , 2003, Nucleic acids research.

[7]  D. Pessayre,et al.  Tamoxifen Inhibits Topoisomerases, Depletes Mitochondrial DNA, and Triggers Steatosis in Mouse Liver , 2007, Journal of Pharmacology and Experimental Therapeutics.

[8]  M. Ehrlich,et al.  The 5-methylcytosine content of highly repeated sequences in human DNA. , 1983, Nucleic acids research.

[9]  P. Pedersen,et al.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen , 2007, Journal of bioenergetics and biomembranes.

[10]  Resistance of Mitochondrial DNA-depleted Cells against Cell Death , 2004, Journal of Biological Chemistry.

[11]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[12]  S. Weinhouse.  On respiratory impairment in cancer cells. , 1956, Science.

[13]  C. Sapienza,et al.  Ooplasmic donation in humans: the potential for epigenic modifications. , 2002, Human reproduction.

[14]  S. Rajaraman,et al.  Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[15]  Eusebi,et al.  Eosinophilic and granular cell tumors of the breast. , 1999, Seminars in diagnostic pathology.

[16]  G. Tallini.  Oncocytic tumours , 1998, Virchows Archiv.

[17]  John K Field,et al.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer , 2005, Genes, chromosomes & cancer.

[19]  G. Bailliet,et al.  Nuclear and mitochondrial genome instability in human breast cancer. , 2000, Cancer research.

[20]  Y. Hayashizaki,et al.  An expanded system of restriction landmark genomic scanning (RLGS Ver. 1.8) , 1995, Electrophoresis.

[21]  D. A. Clayton,et al.  Replication and transcription of vertebrate mitochondrial DNA. , 1991, Annual review of cell biology.

[22]  G. Bailliet,et al.  Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. , 1995, Cytogenetics and cell genetics.

[23]  Pen-Hui Yin,et al.  Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers , 2005, Annals of the New York Academy of Sciences.

[24]  J. Modica-Napolitano,et al.  Mitochondria and human cancer. , 2007, Current molecular medicine.

[25]  D. Johns.  Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. , 1995, The New England journal of medicine.

[26]  C. Plass,et al.  A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. , 1999, Genomics.

[27]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer , 2005, Genes, chromosomes & cancer.

[28]  C. Plass,et al.  Methylation matters , 2001, Journal of medical genetics.

[29]  Joseph Geradts,et al.  Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. , 2005, Gene.

[30]  N. Bianchi,et al.  Mitochondrial genome instability in human cancers. , 2001, Mutation research.

[31]  G. Schatz.  The Protein Import System of Mitochondria* , 1996, The Journal of Biological Chemistry.

[32]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Jones,et al.  Cancer: Death and methylation , 2001, Nature.

[34]  Keshav K. Singh.  Mitochondrial DNA Mutations in Aging, Disease and Cancer , 1998, Springer Berlin Heidelberg.

[35]  Keshav K. Singh,et al.  Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer cells , 2006 .

[36]  Ruifang Niu,et al.  Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients , 2007, IUBMB life.

[37]  C Eng,et al.  Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. , 2001, Human molecular genetics.

[38]  Colin C. Collins,et al.  Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors , 2002, Nature Genetics.

[39]  A. Chomyn.  Platelet-mediated transformation of human mitochondrial DNA-less cells. , 1996, Methods in enzymology.

[40]  Keshav K. Singh,et al.  Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors , 2005, Cancer biology & therapy.

[41]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[42]  D. Clayton.  Transcription and replication of mitochondrial DNA. , 2000, Human reproduction.

[43]  Keshav K. Singh,et al.  Mitochondrial DNA determines the cellular response to cancer therapeutic agents , 1999, Oncogene.

[44]  H. C. Lee,et al.  Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma , 2004, British Journal of Cancer.

[45]  M. Caligiuri,et al.  A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. , 2004, Genomics.

[46]  T. Kakuda,et al.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.

[47]  J. Cohen,et al.  Mitochondria in human offspring derived from ooplasmic transplantation. , 2001, Human reproduction.

[48]  J. Hayashi,et al.  Isolation and characterization of mitochondrial DNA-less lines from various mammalian cell lines by application of an anticancer drug, ditercalinium. , 1997, Biochemical and biophysical research communications.

[49]  L. Rasmussen,et al.  Mitochondria as determinant of nucleotide pools and chromosomal stability. , 2007, Mutation research.

[50]  C. Plass,et al.  The study of aberrant methylation in cancer via restriction landmark genomic scanning , 2002, Oncogene.

[51]  C. Plass,et al.  Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC) , 2003, Journal of medical genetics.

[52]  Wei-Guo Zhu,et al.  A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. , 2003, Human molecular genetics.

[53]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[54]  Saroj P. Mathupala,et al.  Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. , 1996, Cancer research.

[55]  Kathy Pfeiffer,et al.  Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.

[56]  Ivan H. Still,et al.  Proteomic analysis of proteins involved in mitochondria-to-nucleus retrograde response in human cancer cells , 2006 .

[57]  E. Shoubridge,et al.  Mitochondrial genetics and human disease , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[58]  N. Avadhani,et al.  Mitochondrial signaling: the retrograde response. , 2004, Molecular cell.

[59]  J. Rosai,et al.  Oncocytic carcinoma (malignant oncocytoma) of the breast. , 1998, The American journal of surgical pathology.

[60]  J. Modica-Napolitano,et al.  Mitochondria as targets for detection and treatment of cancer , 2002, Expert Reviews in Molecular Medicine.

[61]  R. Wenger,et al.  Restriction Landmark Genomic Scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations , 2007, BMC Genomics.

[62]  C. Plass,et al.  Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors , 2002, Oncogene.

[63]  S. Weller,et al.  Herpes simplex virus eliminates host mitochondrial DNA , 2007, EMBO reports.

[64]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.